Global Cancer Diagnostics Market - PowerPoint PPT Presentation

About This Presentation
Title:

Global Cancer Diagnostics Market

Description:

Global Cancer Diagnostics Market is expected to rise from its initial estimated value of USD 143.89 billion in 2018 to a projected value of USD 244.28 billion by 2026, registering a CAGR of 6.84% in the forecast period of 2019-2026. – PowerPoint PPT presentation

Number of Views:31
Slides: 7
Provided by: nileshdbmr
Category:

less

Transcript and Presenter's Notes

Title: Global Cancer Diagnostics Market


1
Global Cancer Diagnostics Market Industry
Trends - Forecast to 2026
Global Cancer Diagnostics Market By Technology
(Instrument Based, Platform-Based, Tumor
Biomarker Tests), Application (Breast Cancer,
Colorectal Cancer, Cervical Cancer, Lung Cancer,
Prostate Cancer, Skin Cancer, Blood Cancer,
Kidney Cancer, Pancreatic Cancer, Ovarian Cancer,
Others), End-User (Cancer Research Institutes,
Diagnostic Laboratories, Hospitals, Others),
Geography (North America, South America, Europe,
Asia-Pacific, Middle East and Africa)
Browse Full Report and Details TOC
https//www.databridgemarketresearch.com/reports/
global-cancer-diagnostics-market
2
Report Description
Global Cancer Diagnostics Market is expected to
rise from its initial estimated value of USD
143.89 billion in 2018 to a projected value of
USD 244.28 billion by 2026, registering a CAGR of
6.84 in the forecast period of
2019-2026. Cancer diagnostics is the process of
detecting various biomarkers, proteins and
certain symptoms that result in the detection of
presence of cancerous tumor in the patients. The
detection of certain biomarkers and proteins that
are prevalent in cancer disorders thereby result
in the diagnosis process. The process of
detecting cancer includes usage of certain
technology and devices specifically used in its
diagnosis.
3
Major Key Players
  • Some of the major players operating in this
    market are
  • Abbott
  • Agilent Technologies, Inc.
  • BD
  • bioMérieux SA
  • NeoGenomics Laboratories, Inc.
  • Telerad Tech
  • F. Hoffmann-La Roche Ltd
  • GENERAL ELECTRIC COMPANY
  • Hologic Inc.
  • Illumina, Inc.
  • QIAGEN
  • BioGenex

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
cancer-diagnostics-market
4
Market Segmentation
By Technology (Instrument Based, Platform-Based,
Tumor Biomarker Tests) By Application (Breast
Cancer, Colorectal Cancer, Cervical Cancer, Lung
Cancer, Prostate Cancer, Skin Cancer, Blood
Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian
Cancer, Others) By End-User (Cancer Research
Institutes, Diagnostic Laboratories, Hospitals,
Others) By Geography (North America, South
America, Europe, Asia-Pacific, Middle East and
Africa)
Get Exclusive Sample Report _at_ https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-cancer-diagnostics-market
5
Regional Analysis
  • Based on geography, the market is segmented into
    five geographical regions
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East
  • Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com